BIIO — Bionovate Technologies Cashflow Statement
0.000.00%
FinancialsHighly SpeculativeMicro Cap
- $0.00m
- $0.19m
Annual cashflow statement for Bionovate Technologies, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2017 June 30th | 2018 June 30th | 2019 June 30th | 2020 June 30th | 2021 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.341 | -1.74 | -0.209 | -0.122 | -0.107 |
| Non-Cash Items | 0.268 | 1.63 | 0.142 | 0.054 | 0.052 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.083 | 0.107 | 0.067 | 0.068 | 0.054 |
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | 0.011 | 0 | 0 | 0 | 0 |
| Other Investing Cash Flow Items | 0.007 | 0 | — | — | — |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.007 | 0 | — | — | — |
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.018 | 0 | — | — | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.001 | 0 | 0 | 0 | 0 |